| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prelude Therapeutics Inc | Chief Financial Officer | Employee Stock Option (Right to Buy) | 264,329 | 25 Aug 2021 | Direct | ||
| Prelude Therapeutics Inc | Chief Financial Officer | Common Stock | 0 | $3.77 | 25 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 25 Aug 2021 | 5 | -$262,078 | 4 | Chief Financial Officer | 27 Aug 2021, 20:02 |
| PRLD | Prelude Therapeutics Inc | 20 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 22 Jul 2021, 18:09 |
| PRLD | Prelude Therapeutics Inc | 25 May 2021 | 6 | -$269,788 | 4 | Chief Financial Officer | 27 May 2021, 17:03 |